ANALYSIS OF THE ROLE OF RECEPTOR NUMBER IN DEFINING THE INTRINSIC ACTIVITY AND POTENCY OF PARTIAL AGONISTS IN NEUROBLASTOMA X GLIOMA HYBRIDNG108-15 CELLS TRANSFECTED TO EXPRESS DIFFERING LEVELS OF THE HUMAN BETA(2)-ADRENOCEPTOR
Dj. Macewan et al., ANALYSIS OF THE ROLE OF RECEPTOR NUMBER IN DEFINING THE INTRINSIC ACTIVITY AND POTENCY OF PARTIAL AGONISTS IN NEUROBLASTOMA X GLIOMA HYBRIDNG108-15 CELLS TRANSFECTED TO EXPRESS DIFFERING LEVELS OF THE HUMAN BETA(2)-ADRENOCEPTOR, Molecular pharmacology, 48(2), 1995, pp. 316-325
Many agonist ligands are known experimentally to display a range of ef
ficacies and potencies in different tissues and preparations. To analy
ze the role of the levels of receptor expression and availability in t
he intrinsic activities and potencies of agonists, the function of a n
umber of beta-adrenoceptor ligands was examined in clones of neuroblas
toma x glioma hybrid NG108-15 cells transfected to express differing l
evels of the human beta(2)-adrenoceptor, as well as after treatment of
these cell lines with the irreversible beta-adrenoceptor antagonist b
romoacetyl alprenolol menthane (BAAM). Clone beta N22 expressed approx
imately 10-fold higher levels of the receptor than did clone beta N17.
In measurements of agonist stimulation of adenylyl cyclase activity i
n membranes of these cells or agonist stimulation of the formation of
the complex of G(s alpha) and adenylyl cyclase, which acts as the high
affinity binding site for [H-3]forskolin in whole cells, a series of
beta-adrenoceptor agonists, including dichloroisoprenaline, ephedrine,
dobutamine, and salbutamol, displayed higher intrinsic activity and s
howed concentration-response curves that were substantially to the lef
t (lower EC(50) values) in clone beta N22, compared with clone beta N1
7. Treatment of clone beta N22 cells with varying concentrations of BA
AM reduced the intrinsic activity of these ligands and shifted the con
centration-response curves for these agents to the right. In clone bet
a N22 cells and membranes, reduction in the observed intrinsic activit
y for ephedrine required elimination of a smaller fraction of the beta
(2)-adrenoceptor reserve than for salbutamol and reduction in the effe
ct of the full agonists isoprenaline and epinephrine was noted only wi
th high fractional elimination of the receptor pool. The effect of iso
prenaline was substantially reduced, however, by BAAM treatment of clo
ne beta N17 cells, where the beta(2)-adrenoceptor number approached ex
tremely low levels. Analysis of the data using the formalisms of Whale
y et al. [Mel. Pharmacol. 45:481-489 (1994)] showed that prediction of
alterations in agonist potency with receptor number for full agonists
can be adequately extended to partial agonists.